{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:03:32Z","timestamp":1789502612462,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013500","name":"Canadian Cardiovascular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cjca.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T22:16:49Z","timestamp":1591913809000},"page":"822-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Marc W.","family":"Deyell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-6892","authenticated-orcid":false,"given":"Amir","family":"AbdelWahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Angaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne J.","family":"Gula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2156-4625","authenticated-orcid":false,"given":"Isabelle","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-8474","authenticated-orcid":false,"given":"Pablo B.","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Slawnych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Tulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2020.04.004_bib1","first-page":"174","article-title":"Canadian Cardiovascular Society\/Canadian Heart Rhythm Society 2016 implantable cardioverter-defibrillator guidelines","volume":"33","author":"Bennett","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib2","first-page":"1698","article-title":"Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know","volume":"35","author":"Khairy","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1161\/CIR.0000000000000252","article-title":"Part 1: executive summary: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Neumar","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2006.09.020","volume":"48","author":"Buxton","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.resuscitation.2005.04.015","article-title":"Trends in treated ventricular fibrillation in out-of-hospital cardiac arrest: ischemic compared to non-ischemic heart disease","volume":"67","author":"Bunch","year":"2005","journal-title":"Resuscitation"},{"key":"10.1016\/j.cjca.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jcmg.2014.11.017","article-title":"Late gadolinium enhancement among survivors of sudden cardiac arrest","volume":"8","author":"Neilan","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCIMAGING.111.966085","article-title":"Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias","volume":"5","author":"White","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.hrthm.2008.02.036","article-title":"Catheter ablation of bundle branch reentrant ventricular tachycardia","volume":"5","author":"Balasundaram","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib13","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1161\/CIR.0000000000000613","volume":"138","author":"Panchal","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1161\/CIR.0000000000000261","article-title":"Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Link","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1514204","article-title":"Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest","volume":"374","author":"Kudenchuk","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.ijcard.2007.05.052","article-title":"Electrical storm and termination with propofol therapy: a case report","volume":"128","author":"Mulpuru","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib19","first-page":"781","article-title":"Use of dexmedetomidine in sustained ventricular tachycardia","volume":"38","author":"Parent","year":"2010","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.cjca.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/01.CIR.92.11.3255","article-title":"Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group","volume":"92","author":"Kowey","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0735-1097(95)00427-0","article-title":"Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group","volume":"27","author":"Levine","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.118.037997","article-title":"Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction","volume":"139","author":"Komatsu","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","article-title":"Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival","volume":"15","author":"Vergara","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib24","first-page":"110","article-title":"Temporary mechanical circulatory support in cardiac critical care: a state of the art review and algorithm for device selection","volume":"33","author":"Nagpal","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib25","first-page":"1329","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/emermed-2013-202973","article-title":"Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review","volume":"32","author":"deSouza","year":"2015","journal-title":"Emerg Med J"},{"key":"10.1016\/j.cjca.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0002-9149(83)90611-2","article-title":"Hypomagnesemic torsades de pointes","volume":"52","author":"Topol","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.71.2.141","article-title":"Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction","volume":"71","author":"Roffe","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2020.04.004_bib32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCEP.114.001953","article-title":"Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig ventricular tachycardia registry","volume":"7","author":"Dinov","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib35","first-page":"1342","article-title":"2017 Comprehensive update of the Canadian Cardiovascular Society Guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/europace\/eus186","article-title":"Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome","volume":"14","author":"Izquierdo","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10840-017-0291-1","article-title":"Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators","volume":"50","author":"Morawski","year":"2017","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib38","doi-asserted-by":"crossref","first-page":"99F","DOI":"10.1016\/0002-9149(93)90971-E","article-title":"Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators","volume":"72","author":"Singh","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators","volume":"349","author":"Cairns","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2020.04.004_bib40","first-page":"CD008093","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2020.04.004_bib41","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000038499.22687.39","article-title":"Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)","volume":"106","author":"Ellison","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib42","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2020.04.004_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.84.2.558","article-title":"Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators","volume":"84","author":"Levine","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib44","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.amjcard.2011.02.321","article-title":"Relation of ventricular tachycardia\/fibrillation to beta-blocker dose maximization guided by pacing mode analysis in nonpacemaker-dependent patients with implantable cardioverter-defibrillator","volume":"107","author":"Deftereos","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with oral d-sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2020.04.004_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9149(98)00353-1","article-title":"Efficacy of radiofrequency catheter ablation for ventricular tachycardia in healed myocardial infarction","volume":"82","author":"Callans","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib47","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2015.10.026","article-title":"Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial","volume":"66","author":"Di Biase","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib48","first-page":"461","article-title":"Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome","volume":"17","author":"Joza","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2020.04.004_bib49","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib50","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2018.10.016","article-title":"Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study","volume":"16","author":"Mahida","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib51","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.01.029","article-title":"Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars","volume":"43","author":"Soejima","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/jce.13353","article-title":"Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations","volume":"29","author":"AbdelWahab","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0735-1097(00)00606-9","article-title":"Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction","volume":"35","author":"Sosa","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib54","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.hrthm.2010.08.010","article-title":"Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?","volume":"7","author":"Schmidt","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib56","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2010.06.020","article-title":"Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia","volume":"7","author":"Pokushalov","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/europace\/eux056","volume":"19","author":"Berruezo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2020.04.004_bib58","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib59","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCEP.111.962217","article-title":"Epicardial ablation for ventricular tachycardia: a European multicenter study","volume":"4","author":"Della Bella","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib61","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2009.05.032","article-title":"Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy","volume":"54","author":"Cano","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004494","article-title":"Ventricular tachycardia ablation in severe heart failure","volume":"10","author":"Tzou","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib63","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacep.2017.05.005","article-title":"Utilization and in-hospital complications, 2000 to 2013","volume":"3","author":"Hosseini","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCEP.114.001623","article-title":"Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)","volume":"7","author":"Ruwald","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib65","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.hrthm.2016.03.022","article-title":"Extended detection time to reduce shocks is safe in secondary prevention patients: the secondary prevention substudy of PainFree SST","volume":"13","author":"Sterns","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacep.2017.09.004","article-title":"Increased hospitalizations and overall healthcare utilization in patients receiving implantable cardioverter-defibrillator shocks compared with antitachycardia pacing","volume":"4","author":"Sanders","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/CIRCULATIONAHA.114.009468","article-title":"Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial","volume":"130","author":"Kloppe","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib68","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.amjcard.2015.11.052","article-title":"Results of ENHANCED implantable cardioverter defibrillator programming to reduce therapies and improve quality of life (from the ENHANCED-ICD Study)","volume":"117","author":"Mastenbroek","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib69","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1540-8167.2010.01825.x","article-title":"Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial","volume":"21","author":"Saeed","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib70","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10840-009-9454-z","volume":"27","author":"Santini","year":"2010","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/FJC.0b013e31829651fe","article-title":"Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator","volume":"62","author":"Gao","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2020.04.004_bib73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(83)91991-8","article-title":"Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine","volume":"1","author":"Hoffmann","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2020.04.004_bib74","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jce.13431","article-title":"Mexiletine or catheter ablation after amiodarone failure in the VANISH trial","volume":"29","author":"Deyell","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib75","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(84)80133-3","article-title":"International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group","volume":"4","year":"1984","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib76","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2010.07.047","article-title":"Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure","volume":"57","author":"Pinter","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1540-8167.2011.02183.x","article-title":"Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies","volume":"23","author":"Baquero","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib78","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/euhj.2001.2679","article-title":"A\u00a0multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease","volume":"22","author":"Boriani","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.04.004_bib79","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pace.12250","article-title":"Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy","volume":"37","author":"Ermakov","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib81","first-page":"98","article-title":"Effectiveness and safety of flecainide in arrhythmogenic right ventricular cardiomyopathy. Archives of Cardiovascular Diseases","volume":"10","author":"Bouvier","year":"2018","journal-title":"Supplements"},{"key":"10.1016\/j.cjca.2020.04.004_bib82","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2012.08.001","article-title":"Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits","volume":"9","author":"Koruth","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","article-title":"Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia","volume":"139","author":"Robinson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.hrthm.2007.09.012","article-title":"Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era","volume":"5","author":"Sacher","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2020.04.004_bib85","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/CIRCULATIONAHA.113.003423","article-title":"Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia","volume":"128","author":"Sapp","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib86","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib87","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIR.0b013e31825d59fd","article-title":"Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association","volume":"126","author":"Dunbar","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2020.04.004_bib88","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/europace\/euq296","article-title":"Pre-implantation implantable cardioverter defibrillator concerns and type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator","volume":"12","author":"Pedersen","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2020.04.004_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2017.03.009","article-title":"Effects of implantable cardioverter\/defibrillator shock and antitachycardia pacing on anxiety and quality of life: a MADIT-RIT substudy","volume":"189","author":"Perini","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2020.04.004_bib90","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/europace\/euv220","article-title":"Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress","volume":"18","author":"Thylen","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2020.04.004_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.12.011","article-title":"Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey","volume":"157","author":"Kelley","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2020.04.004_bib92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2011.08.011","article-title":"Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care","volume":"109","author":"Kirkpatrick","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2020.04.004_bib93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0269216317718438","article-title":"Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: a cross-sectional survey","volume":"32","author":"McEvedy","year":"2018","journal-title":"Palliat Med"},{"key":"10.1016\/j.cjca.2020.04.004_bib94","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.113.006939","article-title":"Implantable cardioverter-defibrillator shocks in dying patients: disturbing data from beyond the grave","volume":"129","author":"Lampert","year":"2014","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20303263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20303263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:40Z","timestamp":1760107360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X20303263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0828282X20303263"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2020.04.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}